The paediatric oncology unit at this hospital provides an oncology service to the south west of England. Patients from the region come to Bristol for diagnosis and evaluation and to begin treatment. When it is appropriate care is shared between the referring unit and the unit in Bristol.
When a diagnosis is made an information pack is sent to the child's general practitioner giving the diagnosis, describing the unit, and giving details of treatment and probable side effects, thus ensuring a firm link between the specialist unit and the primary care team.' The ensuing period of intense treatment, however, requires close supervision by the hospital, which creates strong links between the families and the specialist unit. We try to keep the general practitioner informed of any important events that occur during treatment. A family support nurse gets to know the family while the child is being treated and as needed visits the child's home to give psychological support, provide family education, and carry out blood tests and physical assessment.
In the event that treatment fails the doctors and the family together decide that anticancer treatment is no longer appropriate, and the emphasis of care changes to relieving physical and mental distress. The aim is to give that child as good a quality of life as possible in the time left to BMJ VOLUME 298 One of these patients (case 3) received diamorphine through a central venous catheter and required rapidly escalating doses of diamorphine -a 14-fold increase in the first eight days. On the day she died it was necessary to increase the dose a further threefold to control the pain. Pain in the second patient (case 9) was controlled initially with slow release morphine and occasional doses of diamorphine in between. Four days before his death severe limb pain led to loss of pain control with oral slow release morphine sulphate and he was started on an intravenous infusion pump, which gave good pain relief over the final three days. The doses required in his final days were some 15 times higher than those given orally allowing for different bioavailability. The third patient (case 10) required large doses ofdiamorphine intravenously in his last few hours when his pain escalated suddenly. We learnt not to hesitate to increase the dose of diamorphine, occasionally giving doses over 1 g four hourly to achieve control of pain.
Antiemetics
Six patients were taking antiemetics regularly. Of these, four had raised intracranial pressure and the use of antiemetics preceded or coincided with the use of diamorphine. Only two patients required antiemetics for nausea and vomiting possibly induced by diamorphine; this was easily controlled in both. The drug chosen was prochlorperazine, which was given either intravenously or rectally. Chlorpromazine and promethazine were also used. Reasonable control of BMJ VOLUME 298vomiting was achieved in all patients except one (case 3), who had widespread disease of the central nervous system from a retinoblastoma.
Steroids
Two patients were taking dexamethasone for raised intracranial pressure at some time during their terminal illness. In case 4 this was tailed off before death, but in case 12 treatment continued until death.
Anticonvulsants
Two patients required anticonvulsant drugs. One took carbamazepine regularly for temporal lobe attacks and the other (case 3) had a seizure as a terminal event. Parents of patients in whom there was a high chance of seizures occurring were given diazepam to administer rectally or intravenously and instructed in its use.
Laxatives
All patients taking diamorphine were given laxatives. Enemas were required by one patient (case 3), who had spinal cord compression from tumour that complicated her management, and two patients required occasional enemas.
Miscellaneous
One patient took trimeprazine for sedation at night and one oral diazepam for anxiety. We did not prescribe sedatives for other patients, though sedation occurred as a side effect of analgesic or antiemetic drugs, or both. A patient who was in incipient cardiac failure from cardiomyopathy induced by anthracyclines (case 7) was treated with digoxin and frusemide; he was the only patient to receive intravenous antibiotics at home as terminal care was started while he was being treated for a neutropenic fever. His quality of life was excellent at the time and so it was decided not to precipitate a possible septicaemia.
RADIOTHERAPY
Five of the 13 patients received palliative radiotherapy to six sites. Two patients were treated for enlarging, painful lymph nodes in the neck, caused by acute myeloid leukaemia in one and by metastatic neuroblastoma in one. In both patients lymph node shrinkage was achieved with three doses of 500 cGy over six days with minimal upset. The first (case 5), who had a thalamic astrocytoma, received 2500 cGy in 10 fractions to the brain stem at time of relapse; there was slight improvement initially, though it is impossible to judge how this influenced her final illness. The second (case 6), who had metastatic rhabdomyosarcoma, had palliative radiotherapy to the very large primary tumour in his calf, which was threatening to fungate before his death from chest metastases. He received 3500 cGy in five fractions over 14 days; he died 63 days later with the skin over his calf intact. Two patients received radiotherapy to limbs for bone pain. One patient (case 11), who had metastatic neuroblastoma, received a single 500 cGy fraction to the thigh, after which she was able to ride her bicycle without needing more analgesics. The other (case 13), who had acute lymphoblastic leukaemia, also received a single 500 cGy fraction to both thighs; her analgesic requirement remained stable for 13 days. Excellent liaison between the paediatric oncology department and the radiotherapy centre meant that it was possible to arrange radiotherapy immediately.
CHEMOTHERAPY
One patient (case 1) received intrathecal chemotherapy for palliation of symptoms of raised intracranial pressure. It produced an improvement in symptoms and was repeated once when headache and vomiting recurred. The aim of intrathecal chemotherapy in this boy was to control his central nervous system disease, which would produce a painful and unpleasant death. Death from bone marrow failure usually is less distressing. Mouthcare packs were required for 11 patients, sheep.
skins for nine, incontinence aids for six, and buggies for five. Ripple mattresses were provided for three and Spenco mattresses for three. One each of the following was also provided: syringe driver, nasogastric suction apparatus, and an intercom. The hospital was largely responsible for the aids for 10 patients and the community for aids for two patients. The family support nurse was responsible for a large part of the terminal care. She visited patients often, the number of visits ranging from 1-32, mean 12. She also telephoned the families. She gave counselling and support, practical advice, and advice about drugs. She also saw that the families got many of the aids required at home to make the child more comfortable and help the parents to care for the child.
Mode of death
Eleven of the 13 patients died in a coma; this was gradual in seven and sudden in three, and one patient developed pneumonia and died peacefully 24 hours later. In two patients death was traumatic, one associated with seizures and haematemesis, the other preceded by a sudden onset of severe pain and the need for an increase in the dose of diamorphine. One BMJ VOLUME 298
8 APRIL 1989 further patient (case 5) had seizures on the day of death, despite the family having diazepam for rectal administration.
Bereavement Bereavement care was largely carried out by the family support nurse, though all families were visited at home by a member of the medical team after the child's death and one or two members of the terminal care team attended each funeral. A mean of eight bereavement vitist were made to each family in the first year after death. Parents were encouraged to visit the hospital if they felt able, and all were offered a consultation with the consultant paediatric oncologist after the child's death at a venue outside the hospital if they preferred.
Discussion
Many parents wish to care for their dying child at home. By working closely with general practitioners and educating and supporting parents we can achieve this. The parents gain confidence through knowing that the hospital team (on whom they may have become dependent) wishes to continue caring for their child at home with the general practitioner and that the hospital facilities are available to them if required. Knowing the likely course ofa particular disease allows the care team to anticipate distressing symptoms and be able to deal with them effectively with the parents.
Potential symptoms in the 13 children that were preempted or treated promptly included pain, constipation, vomiting, seizures, and bleeding. The likely site of pain, its cause, and how it could be relieved was discussed with the child's parents so that they knew, for example, that a child with leukaemia was likely to develop limb pain from bone marrow infiltration and that this could be readily relieved with radiotherapy. All parents were well informed about the use of diamorphine, how to titrate the dose against pain, and the likely side effects-for example, that drowsiness would probably improve after 24-48 hours, but constipation was guaranteed if laxatives were not given. They therefore felt confident that they could keep their child free of pain. If the child was taking non-opiate analgesics they knew opiates were available when needed or, if appropriate, were supplied with opiates and instructions for their use.
There was a large variation in the dose of opiates needed. Most patients were taking oral analgesics, but the presence of a central venous catheter was helpful in three patients in whom oral treatment was not possible during their terminal illness. This is of particular value in very young children or children who fear needles. We now consider placing central venous catheters in patients in whom pain and bleeding are likely to be major problems in terminal care.
Most parents were familiar with the use of antiemetics because of previous chemotherapy. All, however, were warned that if nausea or vomiting occurred antiemetics could be given by a suitable route. When seizures were a possibility diazepam for rectal administration was kept in the home for emergency use.
Bleeding is very distressing to both child and parent. Multiple transfusions of platelets were not necessary for our patients, though three patients received one transfusion each and one patient two transfusions for bleeding. Platelets were given only when signs of bleeding occurred (and were not given prophylactically).
Bleeding from the gums can sometimes be managed with tranexamic acid ifthere is no haematuria and so no risks of clotting in the renal tract. Scrupulous attention to oral hygiene is important in prevention here.
Topical thrombin was used once in one patient without success, but it is sometimes successful. It is now available only on a named patient basis.
In three patients there was loss of pain control. In two this occurred on their final day and their deaths were not peaceful. In one of these seizures occurred, too, contributing to a traumatic death. We are now prepared to use very large doses of diamorphine and to be more specific with our instructions concerning the use of anticonvulsant drugs. Despite our aims of keeping the children free of distressing symptoms and preparing for a peaceful death, we failed to achieve this in three patients.
The likely mode of death of each child was discussed with their parents. This is something that causes considerable anxiety, and Kohler and Radford' found that over half the parents in their study expressed anxiety about what would happen at the moment of death. Most of the children in our study and theirs died peacefully. It is therefore possible to offer reassurance on this point and be correct in most cases.
Expecting and preventing symptoms, the liaison between the hospital and the primary health care team, and the work of the family support nurse who helped that liaison were all important. Once a decision for terminal care at home had been taken the child no longer attended the oncology unit routinely, and medical and nursing assessment was carried out in the home. Parents, however, had access to hospital medical staff for advice by telephone at all times. Drug control remained in the hands of the hospital team in most cases.
Most children who are terminally ill can be supported at home, should this be the wish of the child and parent.
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